2020 Speakers

OTS 2020 Speakers

Ike Ahmed, MD

Prism Eye Institute

Bobak Azamian, MD, PhD

CEO, Tarsus Pharmaceuticals

Kelly Barba

Chair, Women Leaders of Octane and Associate Director of Client Development, K&L Gates

Dave Barton

Co-founder & CEO, Optify

John Berdahl, MD

CEO, Equinox, Melt Pharmaceuticals

Alfred Bowen

ANMT, FR / FRC, NASM-CES, NESTA-MPT, CMT, Massage Therapist

Marc Belotti

Senior Advisor, Octane LaunchPad

Philippe Calais, PhD

Founder & CEO, Phileas Pharma

Bill Carpou

CEO, Octane

Anthony Chang, MD, MBA, MPH, MS

Chief Intelligence and Innovation Officer, CHOC

Jeff Estes

Shareholder, Stradling

Robert Dempsey

CEO, TearClear

Jag Dosanjh

Senior Vice President, Medical Therapeutics (Eye Care & Botox Therapeutics), Allergan, an AbbVie Company

Warren Foust

Worldwide President, Surgical Vision, J&J Vision

Mike Giaquinto

Senior Managing Director, SVB Leerink

Laurie Ferguson

Head of Ophthalmic Devices Global Communications, ZEISS Medical Technology Business Group

Adrienne Graves, PhD

Prior CEO of Santen US, Board Member for Glaucoma Research Foundation & other private and public companies

Ranya Habash, MD

Consultant, Microsoft, Chief Medical Officer, Everbridge, Medical Director, Technology Innovation, Bascom Palmer Eye Institute, University of Miami

Deb Hart

Managing Director, Octane Enterprise Solutions

Kamran Hosseini, MD, PhD

President & CEO, Surface Pharmaceuticals, Inc.

John Hovanesian, MD, FACS

Private Practice, Harvard Eye Associates, Laguna Hills, CA Clinical Faculty, UCLA Jules Stein Eye Institute, Los Angeles, CA

Sean Ianchulev, MD, MPH

Professor of Ophthalmology, NYEE, CEO, Eyenovia, Found, IanTECH

Elad Kedar

CEO, Orasis Pharmaceuticals

Curt LaBelle

President, Global Health Investment Fund

Matt Larson

President & CEO, Equinox

Richard Lindstrom

Director, Surface Pharmaceuticals, Inc.

Bill Link, PhD

Managing Partner, Flying L Partners

Abigail Markward

President-Elect/Vice President, OWL and Director Business Development – Western Region, PentaVision & National Director, PentaVision Live!

Robert Maloney, MD

Maloney Vision Institute

Jim Mazzo

Chairman of the Board, Octane, Advisor, ZEISS, Executive Chairman, Avellino, Advisor, Bain Capital

Tom Mitro

President & COO, Aerie Pharmaceuticals

Jenna Mons Anderson

CEO, Access Elite

Monty Montoya

President & CEO, CorneaGen

Dan Myers

CEO, Leo Lens Pharma

Jinsong Ni

CEO & CSO, Cloudbreak Therapeutics

Michael Onuscheck

President, Global Business & Innovation, Alcon

Jeremy Poincenot

Inspirational Speaker & Blind Golf Champion

David Pyott

Former CEO, Allergan

Tal Raviv, MD, FACS

Eye Center of New York

Sherri Rowen, MD

NVISION Eye Center

JC Ruffalo

Director, LaunchPad SBDC, Octane

Karolinne Rocha, MD, PhD

University of South Carolina

Ehsan Sadri, MD, FACS

Founder & CEO, Visionary Eye Institute

Michael Severino, MD

Vice-Chairman & President, AbbVie

Allison Shuren

Partner, Arnold & Porter

Inder Paul Singh, MD

Eye Centers of Racine & Kenosha

Jas Tilghman, PhD

Psychologist

Marty Waters

Partner, Wilson Sonsini

Jeffry Weinhuff

Managing Partner, Visionary Venture Fund

Elizabeth Yeu, MD

Partner, Virginia Eye Consultants